FibroGen, Inc.
FGEN
$0.318
-$0.0001-0.03%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/5/2025
-
GuruFocus
5/5/2025
-
Globe Newswire
4/8/2025
-
Simply Wall St
4/2/2025
-
GuruFocus
4/2/2025
-
Globe Newswire
3/28/2025
-
The Fly
3/28/2025
-
GuruFocus
3/28/2025
-
Globe Newswire
3/18/2025
-
GuruFocus
3/18/2025
-
GuruFocus
3/18/2025
-
TipRanks Financial Blog
3/18/2025
-
SeekingAlpha
3/18/2025
-
Seeking Alpha: Transcripts
3/17/2025
-
GuruFocus
3/17/2025
-
GuruFocus
3/17/2025
-
The Fly
3/17/2025
-
Globe Newswire
3/17/2025
-
TipRanks Financial Blog
3/17/2025
-
The Fly
3/3/2025
-
GuruFocus
3/3/2025
-
Globe Newswire
2/24/2025
-
GuruFocus
2/22/2025
-
MarketBeat
2/21/2025
-
MarketBeat
2/21/2025
-
Simply Wall St
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 17, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
415 978 1200
Address
350 Bay Street
San Francisco, CA 94133
San Francisco, CA 94133
Country
Year Founded
Business Description
Sector
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Roxadustat, a small...
more